News | February 27, 2009

Mercy Hospital First in Miami-Dade to Implant Insertable Cardiac Monitor

February 27, 2009 - Dr. Alberto Interian Jr., medical director of the Mercy Hospital Arrhythmia Syncope Center, is the first doctor in Miami-Dade County, FL to implant an innovative cardiac monitoring device for patients with irregular heart rhythms (arrhythmias), or recurrent, unexplained fainting (syncope).
The Medtronic Reveal XT Insertable Cardiac Monitor (ICM) device monitors patients 24 hours a day, every day for up to three years, recording important cardiac rhythm trend data that may allow a physician to confirm or rule out an abnormal heart rhythm more definitively than other tests.

“Cardiac arrhythmias are unpredictable,” said Dr. Interian. “The Reveal XT device gives me a long-term monitoring option that further assists me in making a diagnosis and determining the appropriate treatment for my patients.”

Physicians may choose the Reveal XT monitor for their patients with suspected arrhythmias in difficult-to-diagnose patients for whom long-term cardiac rhythm trending data may aid in a more informed diagnosis; or in syncope patients with known or suspected atrial fibrillation (AF), where the heart quivers and cannot effectively pump blood to the body’s organs.

The ICMs are also an option for physicians seeking to detect the presence of atrial arrhythmias (irregular heart rhythms in the upper chambers, also known as AT), including asymptomatic episodes, or to monitor the amount of time a patient is in AT/AF to assess whether medical treatment is necessary or should be adjusted.

Placed just under the skin of the chest area using local anesthesia during a simple outpatient procedure, the device weighs just 15 grams and is approximately the size of a jump drive. Unlike a pacemaker or implantable cardioverter-defibrillator, there are no leads or tiny wires that extend from the device into the heart’s chambers. To store an electrocardiogram (ECG), a patient places a hand-held, pager-sized assistant over the device and presses a button. The physician can then analyze the stored information, transmitted via the Medtronic CareLink Network or during an in-office patient visit, and determines whether the episode was caused by an abnormal heart rhythm.

For more information:

Related Content

Societies Detail Treatment for Patients With Ventricular Arrhythmias
News | EP Lab| October 30, 2017
The American College of Cardiology, along with the American Heart Association and the Heart Rhythm Society, published...
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab| September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Spectranetics Bridge Occlusion Balloon in the SVC

An illustration of how the Bridge balloon can seal the SVC after an accidental tear from lead extration.

Feature | EP Lab| May 17, 2017 | Dave Fornell
May 17, 2017 — A new intravenous occlusion balloon designed to seal any accidental tears in the superior vena cava (S
Overlay Init